Alzheimer's disease amyloid β-protein and synaptic function

Philosophical transactions of the Royal Society of London. B

Press, H. (1886) · Cited by 10,087

A JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

Lindemann, L., Jaeschke, G., Michalon, A., Vieira, E., Honer, M., Spooren, W., Porter, R., Hartung, T., Kolczewski, S., Büttelmann, B., et al. (1909) · JAMA · doi:10.1001/jama.1909.02550020033007 · Cited by 7,889

Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid β-peptide

Haass, C., & Selkoe, D. J. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2101 · Cited by 4,744

Naturally secreted oligomers of amyloid β protein potently inhibit hippocampal long-term potentiation in vivo

Walsh, D. M., Klyubin, I., Fadeeva, J. V., Cullen, W. K., Anwyl, R., Wolfe, M. S., Rowan, M. J., & Selkoe, D. J. (2002) · Nature · doi:10.1038/416535a · Cited by 4,291

Amyloid-β protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory

Shankar, G. M., Li, S., Mehta, T. H., Garcia-Munoz, A., Shepardson, N. E., Smith, I., Brett, F. M., Farrell, M. A., Rowan, M. J., Lemere, C. A., et al. (2008) · Nature Medicine · doi:10.1038/nm1782 · Cited by 3,685

Diffusible, nonfibrillar ligands derived from Aβ 1–42 are potent central nervous system neurotoxins

Lambert, M. P., Barlow, A. K., Chromy, B. A., Edwards, C., Freed, R., Liosatos, M., Morgan, T. E., Rozovsky, I., Trommer, B., Viola, K. L., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.11.6448 · Cited by 3,506

Long-Term Potentiation and Memory

Lynch, M. A. (2004) · Physiological Reviews · doi:10.1152/physrev.00014.2003 · Cited by 2,074

Natural oligomers of the amyloid-β protein specifically disrupt cognitive function

Cleary, J. P., Walsh, D. M., Hofmeister, J. J., Shankar, G. M., Kuskowski, M. A., Selkoe, D. J., & Ashe, K. H. (2004) · Nature Neuroscience · doi:10.1038/nn1372 · Cited by 1,722

APP Processing and Synaptic Function

Kamenetz, F., Tomita, T., Hsieh, H., Seabrook, G., Borchelt, D., Iwatsubo, T., Sisodia, S., & Malinow, R. (2003) · Neuron · doi:10.1016/s0896-6273(03)00124-7 · Cited by 1,644

beta-Amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity

Mattson, M. P., Cheng, B., Davis, D. G., Bryant, K., Lieberburg, I. M., & Rydel, R. E. (1992) · Journal of Neuroscience · doi:10.1523/jneurosci.12-02-00376.1992 · Cited by 1,633

Natural Oligomers of the Alzheimer Amyloid-β Protein Induce Reversible Synapse Loss by Modulating an NMDA-Type Glutamate Receptor-Dependent Signaling Pathway

Shankar, G. M., Bloodgood, B. L., Townsend, M., Walsh, D. M., Selkoe, D. J., & Sabatini, B. L. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.4970-06.2007 · Cited by 1,592

Regulation of NMDA receptor trafficking by amyloid-β

Snyder, E. M., Nong, Y., Almeida, C. G., Paul, S., Moran, T., Choi, E. Y., Nairn, A. C., Salter, M. W., Lombroso, P. J., Gouras, G. K., et al. (2005) · Nature Neuroscience · doi:10.1038/nn1503 · Cited by 1,561

Cellular prion protein mediates impairment of synaptic plasticity by amyloid-β oligomers

Laurén, J., Gimbel, D. A., Nygaard, H. B., Gilbert, J. W., & Strittmatter, S. M. (2009) · Nature · doi:10.1038/nature07761 · Cited by 1,560

Soluble Amyloid β Peptide Concentration as a Predictor of Synaptic Change in Alzheimer's Disease

Lue, L.-F., Kuo, Y.-M., Roher, A. E., Brachova, L., Shen, Y., Sue, L., Beach, T., Kurth, J. H., Rydel, R. E., & Rogers, J. (1999) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65184-x · Cited by 1,530

Aβ peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease

Janus, C., Pearson, J., McLaurin, J., Mathews, P. M., Jiang, Y., Schmidt, S. D., Chishti, M. A., Horne, P., Heslin, D., French, J., et al. (2000) · Nature · doi:10.1038/35050110 · Cited by 1,431

Aβ Oligomer-Induced Aberrations in Synapse Composition, Shape, and Density Provide a Molecular Basis for Loss of Connectivity in Alzheimer's Disease

Lacor, P. N., Buniel, M. C., Furlow, P. W., Sanz Clemente, A., Velasco, P. T., Wood, M., Viola, K. L., & Klein, W. L. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.3501-06.2007 · Cited by 1,188

NMDA receptor trafficking in synaptic plasticity and neuropsychiatric disorders

Lau, C. G., & Zukin, R. S. (2007) · Nature Reviews Neuroscience · doi:10.1038/nrn2153 · Cited by 1,159 · cited 2×

Clusters of Hyperactive Neurons Near Amyloid Plaques in a Mouse Model of Alzheimer’s Disease

Busche, M. A., Eichhoff, G., Adelsberger, H., Abramowski, D., Wiederhold, K.-H., Haass, C., Staufenbiel, M., Konnerth, A., & Garaschuk, O. (2008) · Science · doi:10.1126/science.1162844 · Cited by 1,125

AMPAR Removal Underlies Aβ-Induced Synaptic Depression and Dendritic Spine Loss

Hsieh, H., Boehm, J., Sato, C., Iwatsubo, T., Tomita, T., Sisodia, S., & Malinow, R. (2006) · Neuron · doi:10.1016/j.neuron.2006.10.035 · Cited by 1,042

Soluble Oligomers of Amyloid β Protein Facilitate Hippocampal Long-Term Depression by Disrupting Neuronal Glutamate Uptake

Li, S., Hong, S., Shepardson, N. E., Walsh, D. M., Shankar, G. M., & Selkoe, D. (2009) · Neuron · doi:10.1016/j.neuron.2009.05.012 · Cited by 972

Early-onset Amyloid Deposition and Cognitive Deficits in Transgenic Mice Expressing a Double Mutant Form of Amyloid Precursor Protein 695

Chishti, M. A., Yang, D.-S., Janus, C., Phinney, A. L., Horne, P., Pearson, J., Strome, R., Zuker, N., Loukides, J., French, J., et al. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m100710200 · Cited by 955

Cholinergic systems in mammalian brain and spinal cord

WOOLF, N. (1991) · Progress in Neurobiology · doi:10.1016/0301-0082(91)90006-m · Cited by 948

Glutamate-mediated excitotoxicity and neurodegeneration in Alzheimer?s disease

HYND, M. (2004) · Neurochemistry International · doi:10.1016/j.neuint.2004.03.007 · Cited by 938

Aβ Oligomers Induce Neuronal Oxidative Stress through an N-Methyl-D-aspartate Receptor-dependent Mechanism That Is Blocked by the Alzheimer Drug Memantine

De Felice, F. G., Velasco, P. T., Lambert, M. P., Viola, K., Fernandez, S. J., Ferreira, S. T., & Klein, W. L. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m607483200 · Cited by 882

β-Amyloid1–42 Binds to α7 Nicotinic Acetylcholine Receptor with High Affinity

Wang, H.-Y., Lee, D. H. S., D’Andrea, M. R., Peterson, P. A., Shank, R. P., & Reitz, A. B. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.8.5626 · Cited by 818

Metabotropic glutamate receptors: electrophysiological properties and role in plasticity

Anwyl, R. (1999) · Brain Research Reviews · doi:10.1016/s0165-0173(98)00050-2 · Cited by 799

Roles of amyloid precursor protein and its fragments in regulating neural activity, plasticity and memory

Turner, P. R., O’Connor, K., Tate, W. P., & Abraham, W. C. (2003) · Progress in Neurobiology · doi:10.1016/s0301-0082(03)00089-3 · Cited by 796

Picomolar Amyloid-β Positively Modulates Synaptic Plasticity and Memory in Hippocampus

Puzzo, D., Privitera, L., Leznik, E., Fà, M., Staniszewski, A., Palmeri, A., & Arancio, O. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.2692-08.2008 · Cited by 740

Synchronous Hyperactivity and Intercellular Calcium Waves in Astrocytes in Alzheimer Mice

Kuchibhotla, K. V., Lattarulo, C. R., Hyman, B. T., & Bacskai, B. J. (2009) · Science · doi:10.1126/science.1169096 · Cited by 729

Memantine: a NMDA receptor antagonist that improves memory by restoration of homeostasis in the glutamatergic system - too little activation is bad, too much is even worse

Parsons, C. G., Stöffler, A., & Danysz, W. (2007) · Neuropharmacology · doi:10.1016/j.neuropharm.2007.07.013 · Cited by 724

β-amyloid precursor protein-deficient mice show reactive gliosis and decreased locomotor activity

Zheng, H., Jiang, M., Trumbauer, M. E., SIRINATHSINGHJI, D. J. S., Hopkins, R., Smith, D. W., HEAVENS, R. P., Dawson, G. R., Boyce, S., Conner, M. W., et al. (1995) · Cell · doi:10.1016/0092-8674(95)90073-x · Cited by 699

Effects of Xanomeline, a Selective Muscarinic Receptor Agonist, on Cognitive Function and Behavioral Symptoms in Alzheimer Disease

Bodick, N. C., Offen, W., Levey, A. I., Cutler, N. R., Gauthier, S. G., Satlin, A., Shannon, H. E., Tollefson, G. D., Rasmussen, K., Bymaster, F. P., et al. (1997) · Archives of Neurology · doi:10.1001/archneur.1997.00550160091022 · Cited by 697

Alzheimer’s disease and the basal forebrain cholinergic system: relations to β-amyloid peptides, cognition, and treatment strategies

Auld, D. S., Kornecook, T. J., Bastianetto, S., & Quirion, R. (2002) · Progress in Neurobiology · doi:10.1016/s0301-0082(02)00079-5 · Cited by 678

β-Amyloid protein increases the vulnerability of cultured cortical neurons to excitotoxic damage

Koh, J., Yang, L. L., & Cotman, C. W. (1990) · Brain Research · doi:10.1016/0006-8993(90)91355-k · Cited by 617

The Levels of Soluble versus Insoluble Brain Aβ Distinguish Alzheimer's Disease from Normal and Pathologic Aging

Wang, J., Dickson, D. W., Trojanowski, J. Q., & Lee, V. M.-Y. (1999) · Experimental Neurology · doi:10.1006/exnr.1999.7085 · Cited by 567

Globular amyloid β‐peptide 1−42 oligomer − a homogenous and stable neuropathological protein in Alzheimer's disease

Barghorn, S., Nimmrich, V., Striebinger, A., Krantz, C., Keller, P., Janson, B., Bahr, M., Schmidt, M., Bitner, R. S., Harlan, J., et al. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03407.x · Cited by 559

Nature Reviews Neuroscience

(2019) · Nature reviews. Neuroscience · doi:10.1038/41583.1471-0048 · Cited by 550

The significance of the cholinergic system in the brain during aging and in Alzheimer’s disease

Schliebs, R., & Arendt, T. (2006) · Journal of Neural Transmission · doi:10.1007/s00702-006-0579-2 · Cited by 548

Amnesia induced in mice by centrally administered β-amyloid peptides involves cholinergic dysfunction

Maurice, T., Lockhart, B. P., & Privat, A. (1996) · Brain Research · doi:10.1016/0006-8993(95)01032-7 · Cited by 530

Synaptic degeneration in Alzheimer's disease

Arendt, T. (2009) · Acta Neuropathologica · doi:10.1007/s00401-009-0536-x · Cited by 517

Elements of a neurobiological theory of the hippocampus: the role of activity-dependent synaptic plasticity in memory

Morris, R., Moser, E. I., Riedel, G., Martin, S. J., Sandin, J., Day, M., & O’Carroll, C. (2003) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2002.1264 · Cited by 493

Excitatory amino acids and Alzheimer's disease

Greenamyre, J. T., & Young, A. B. (1989) · Neurobiology of Aging · doi:10.1016/0197-4580(89)90143-7 · Cited by 485

β-Amyloid Activates the Mitogen-Activated Protein Kinase Cascade via Hippocampal α7 Nicotinic Acetylcholine Receptors:In Vitro and In Vivo Mechanisms Related to Alzheimer's Disease

Dineley, K. T., Westerman, M., Bui, D., Bell, K., Ashe, K. H., & Sweatt, J. D. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-12-04125.2001 · Cited by 462

Impairment of Glucose and Glutamate Transport and Induction of Mitochondrial Oxidative Stress and Dysfunction in Synaptosomes by Amyloid β‐Peptide: Role of the Lipid Peroxidation Product 4‐Hydroxynonenal

Keller, J. N., Pang, Z., Geddes, J. W., Begley, J. G., Germeyer, A., Waeg, G., & Mattson, M. P. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.69010273.x · Cited by 439 · cited 2×

Properties of Neuronal Nicotinic Acetylcholine Receptors: Pharmacological Characterization and Modulation of Synaptic Function,

Albuquerque, E. X., Alkondon, M., Pereira, E. F. R., Castro, N. G., Schrattenholz, A. S., Barbosa, C. T. F., Bonfante-Cabarcas, R. A., Aracava, Y., Eisenberg, H. M., & Maelicke, A. (1997) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)36503-6 · Cited by 437

Block of Long-Term Potentiation by Naturally Secreted and Synthetic Amyloid β-Peptide in Hippocampal Slices Is Mediated via Activation of the Kinases c-Jun N-Terminal Kinase, Cyclin-Dependent Kinase 5, and p38 Mitogen-Activated Protein Kinase as well as Metabotropic Glutamate Receptor Type 5

Wang, Q., Walsh, D. M., Rowan, M. J., Selkoe, D. J., & Anwyl, R. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.1633-03.2004 · Cited by 437

Timing and Location of Nicotinic Activity Enhances or Depresses Hippocampal Synaptic Plasticity

Ji, D., Lape, R., & Dani, J. A. (2001) · Neuron · doi:10.1016/s0896-6273(01)00332-4 · Cited by 419

Effects of nicotinic stimulation on cognitive performance

NEWHOUSE, P. A. (2003) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2003.11.001 · Cited by 411

Beta-amyloid accumulation in APP mutant neurons reduces PSD-95 and GluR1 in synapses

Almeida, C. G., Tampellini, D., Takahashi, R. H., Greengard, P., Lin, M. T., Snyder, E. M., & Gouras, G. K. (2005) · Neurobiology of Disease · doi:10.1016/j.nbd.2005.02.008 · Cited by 397

Age-related cognitive deficits, impaired long-term potentiation and reduction in synaptic marker density in mice lacking the β-amyloid precursor protein

Dawson, G. R., Seabrook, G. R., Zheng, H., Smith, D. W., Graham, S. J., O'Dowd, G., Bowery, B. J., Boyce, S., Trumbauer, M. E., Chen, H. Y., et al. (1999) · Neuroscience · doi:10.1016/s0306-4522(98)00410-2 · Cited by 394

The Secreted β-Amyloid Precursor Protein Ectodomain APPsα Is Sufficient to Rescue the Anatomical, Behavioral, and Electrophysiological Abnormalities of APP-Deficient Mice

Ring, S., Weyer, S. W., Kilian, S. B., Waldron, E., Pietrzik, C. U., Filippov, M. A., Herms, J., Buchholz, C., Eckman, C. B., Korte, M., et al. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.1026-07.2007 · Cited by 390

The Production of Amyloid β Peptide Is a Critical Requirement for the Viability of Central Neurons

Plant, L. D., Boyle, J. P., Smith, I. F., Peers, C., & Pearson, H. A. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-13-05531.2003 · Cited by 326

Amyloid β Protein Dimer-Containing Human CSF Disrupts Synaptic Plasticity: Prevention by Systemic Passive Immunization

Klyubin, I., Betts, V., Welzel, A. T., Blennow, K., Zetterberg, H., Wallin, A., Lemere, C. A., Cullen, W. K., Peng, Y., Wisniewski, T., et al. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.5161-07.2008 · Cited by 321

Behavioral and anatomical deficits in mice homozygous for a modified ?-amyloid precursor protein gene

Müller, U. (1994) · Cell · doi:10.1016/0092-8674(94)90066-3 · Cited by 315

Decoding NMDA Receptor Signaling: Identification of Genomic Programs Specifying Neuronal Survival and Death

Zhang, S.-J., Steijaert, M. N., Lau, D., Schütz, G., Delucinge-Vivier, C., Descombes, P., & Bading, H. (2007) · Neuron · doi:10.1016/j.neuron.2007.01.025 · Cited by 313

Correlation between Scores for Dementia and Counts of ‘Senile Plaques’ in Cerebral Grey Matter of Elderly Subjects

ROTH, M., TOMLINSON, B. E., & BLESSED, G. (1966) · Nature · doi:10.1038/209109a0 · Cited by 298

The Pathogenesis of Alzheimer Disease: An Alternative to the Amyloid Hypothesis

Terry, R. D. (1996) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199655100-00001 · Cited by 291

β-Amyloid 1–42 Peptide Directly Modulates Nicotinic Receptors in the Rat Hippocampal Slice

Pettit, D. L., Shao, Z., & Yakel, J. L. (2001) · Journal of Neuroscience · doi:10.1523/jneurosci.21-01-j0003.2001 · Cited by 291

Soluble β-Amyloid1-40Induces NMDA-Dependent Degradation of Postsynaptic Density-95 at Glutamatergic Synapses

Roselli, F., Tirard, M., Lu, J., Hutzler, P., Lamberti, P., Livrea, P., Morabito, M. A., & Almeida, O. F. X. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.3034-05.2005 · Cited by 284

β‐Amyloid neurotoxicity is mediated by a glutamate‐triggered excitotoxic cascade in rat nucleus basalis

Harkany, T., Ábrahám, I. M., Timmerman, W., Laskay, G., Tóth, B., Sasvári, M., Kónya, C., Sebens, J. B., Korf, J., Nyakas, C. J., et al. (2000) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2000.00164.x · Cited by 283

Mechanisms contributing to the deficits in hippocampal synaptic plasticity in mice lacking amyloid precursor protein

Seabrook, G. R., Smith, D. W., Bowery, B. J., Easter, A., Reynolds, T., Fitzjohn, S. M., Morton, R. A., Zheng, H., Dawson, G. R., SIRINATHSINGHJI, D. J. S., et al. (1999) · Neuropharmacology · doi:10.1016/s0028-3908(98)00204-4 · Cited by 281

Neuronal viability is controlled by a functional relation between synaptic and extrasynaptic NMDA receptors

Léveillé, F., Gaamouch, F. E., Gouix, E., Lecocq, M., Lobner, D., Nicole, O., & Buisson, A. (2008) · The FASEB Journal · doi:10.1096/fj.08-107268 · Cited by 280

Mg2+Imparts NMDA Receptor Subtype Selectivity to the Alzheimer's Drug Memantine

Kotermanski, S. E., & Johnson, J. W. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.3703-08.2009 · Cited by 271

Nicotinic and muscarinic subtypes in the human brain: Changes with aging and dementia

Nordberg, A. K., Alafuzoff, I. I., & Winblad, B. G. (1992) · Journal of Neuroscience Research · doi:10.1002/jnr.490310115 · Cited by 270

β-Amyloid protein-induced Alzheimer's disease animal model

Nitta, A., Itoh, A., Hasegawa, T., & Nabeshima, T. (1994) · Neuroscience Letters · doi:10.1016/0304-3940(94)90239-9 · Cited by 269

Pathologically activated therapeutics for neuroprotection

Lipton, S. A. (2007) · Nature reviews. Neuroscience · doi:10.1038/nrn2229 · Cited by 268

Excitatory amino acids

Moloney, M. G. (1998) · Natural Product Reports · doi:10.1039/a815205y · Cited by 255

Novel Selective Allosteric Activator of the M1Muscarinic Acetylcholine Receptor Regulates Amyloid Processing and Produces Antipsychotic-Like Activity in Rats

Jones, C. K., Brady, A. E., Davis, A. A., Xiang, Z., Bubser, M., Tantawy, M. N., Kane, A. S., Bridges, T. M., Kennedy, J. P., Bradley, S. R., et al. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.1850-08.2008 · Cited by 248

β-Amyloid-induced Dynamin 1 Degradation Is Mediated by N-Methyl-D-Aspartate Receptors in Hippocampal Neurons

Kelly, B. L., & Ferreira, A. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m605081200 · Cited by 244

β-Amyloid Peptide Activates α7 Nicotinic Acetylcholine Receptors Expressed in Xenopus Oocytes

Dineley, K. T., Bell, K. A., Bui, D., & Sweatt, J. D. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200066200 · Cited by 242

Modulation of Hippocampus-Dependent Learning and Synaptic Plasticity by Nicotine

Kenney, J. W., & Gould, T. J. (2008) · Molecular Neurobiology · doi:10.1007/s12035-008-8037-9 · Cited by 242

Amyloid-beta peptide decreases glutamate uptake in cultured astrocytes: Involvement of oxidative stress and mitogen-activated protein kinase cascades

Matos, M., Augusto, E., Oliveira, C. R., & Agostinho, P. M. (2008) · Neuroscience · doi:10.1016/j.neuroscience.2008.08.022 · Cited by 239

Block of LTP in rat hippocampus in vivo by β-amyloid precursor protein fragments

Cullen, W. K., Suh, Y., Anwyl, R., & Rowan, M. J. (1997) · Neuroreport · doi:10.1097/00001756-199710200-00006 · Cited by 239

Modulation of Synaptic Plasticity by Physiological Activation of M1Muscarinic Acetylcholine Receptors in the Mouse Hippocampus

Shinoe, T., Matsui, M., Taketo, M. M., & Manabe, T. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.2338-05.2005 · Cited by 237

Nicotinic receptor abnormalities in Alzheimer’s disease

COURT, J. A., Martin-Ruiz, C. M., Piggott, M. A., Spurden, D., Griffiths, M., & Perry, E. K. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(00)01116-1 · Cited by 232

A Role for Synaptic Zinc in Activity-Dependent Aβ Oligomer Formation and Accumulation at Excitatory Synapses

Deshpande, A., Kawai, H., Metherate, R., Glabe, C. G., & Busciglio, J. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.5980-08.2009 · Cited by 232

Generation of Aggregated β-Amyloid in the Rat Hippocampus Impairs Synaptic Transmission and Plasticity and Causes Memory Deficits

Stéphan, A., Laroche, S., & Davis, S. (2001) · Journal of Neuroscience · doi:10.1523/jneurosci.21-15-05703.2001 · Cited by 228

Acute stress increases interstitial fluid amyloid-β via corticotropin-releasing factor and neuronal activity

Kang, J.-E., Cirrito, J. R., Dong, H., Csernansky, J. G., & Holtzman, D. M. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0700148104 · Cited by 219

Synaptic plasticity in animal models of early Alzheimer's disease

Rowan, M. J., Klyubin, I. V., Cullen, W. K., & Anwyl, R. (2003) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2002.1240 · Cited by 206

Receptor for Advanced Glycation End Product-Dependent Activation of p38 Mitogen-Activated Protein Kinase Contributes to Amyloid-β-Mediated Cortical Synaptic Dysfunction

Origlia, N., Righi, M., Capsoni, S., Cattaneo, A., Fang, F., Stern, D. M., Chen, J. X., Schmidt, A. M., Arancio, O., Yan, S. D., et al. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.0204-08.2008 · Cited by 206

Acute and chronic nicotine exposure differentially facilitate the induction of LTP

Fujii, S., Ji, Z., Morita, N., & Sumikawa, K. (1999) · Brain Research · doi:10.1016/s0006-8993(99)01982-4 · Cited by 204

Cholinergic Neuronal and Axonal Abnormalities Are Present Early in Aging and in Alzheimer Disease

Geula, C., Nagykery, N. G., Nicholas, A., & Wu, C. (2008) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e31816a1df3 · Cited by 204

Endogenous secreted amyloid precursor protein-α regulates hippocampal NMDA receptor function, long-term potentiation and spatial memory

Taylor, C. J., Ireland, D. R., Ballagh, I. H., Bourne, K., Marechal, N. M., Turner, P. R., Bilkey, D. K., Tate, W. P., & Abraham, W. C. (2008) · Neurobiology of Disease · doi:10.1016/j.nbd.2008.04.011 · Cited by 204

Hippocampal α7 and α4β2 nicotinic receptors and working memory

Levin, E. D., Bradley, A., Addy, N., & Sigurani, N. (2002) · Neuroscience · doi:10.1016/s0306-4522(01)00538-3 · Cited by 202

Deletion of the 7 Nicotinic Acetylcholine Receptor Gene Improves Cognitive Deficits and Synaptic Pathology in a Mouse Model of Alzheimer's Disease

Dziewczapolski, G., Głogowski, M., Masliah, E., & Heinemann, S. F. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.6159-08.2009 · Cited by 199

Use-Dependent Effects of Amyloidogenic Fragments of β-Amyloid Precursor Protein on Synaptic Plasticity in Rat HippocampusIn Vivo

Kim, J., Anwyl, R., Suh, Y., Djamgoz, M. B. A., & Rowan, M. J. (2001) · Journal of Neuroscience · doi:10.1523/jneurosci.21-04-01327.2001 · Cited by 186

β-Amyloid Impairs AMPA Receptor Trafficking and Function by Reducing Ca2+/Calmodulin-dependent Protein Kinase II Synaptic Distribution

Gu, Z., Liu, W., & Yan, Z. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m806508200 · Cited by 185

RAGE and Alzheimer's Disease: A Progression Factor for Amyloid-β-Induced Cellular Perturbation?

Yan, S. D., Bierhaus, A., Nawroth, P. P., & Stern, D. M. (2009) · Journal of Alzheimer s Disease · doi:10.3233/jad-2009-1030 · Cited by 184

Secreted form of β-amyloid precursor protein shifts the frequency dependency for induction of LTD, and enhances LTP in hippocampal slices

Ishida, A., Furukawa, K., Keller, J. N., & Mattson, M. P. (1997) · Neuroreport · doi:10.1097/00001756-199707070-00009 · Cited by 177

Alzheimer Amyloid β-Peptide Inhibits the Late Phase of Long-Term Potentiation through Calcineurin-Dependent Mechanisms in the Hippocampal Dentate Gyrus

Chen, Q.-S., Wei, W., Shimahara, T., & Xie, C.-W. (2002) · Neurobiology of Learning and Memory · doi:10.1006/nlme.2001.4034 · Cited by 176

SSR180711, a Novel Selective α7 Nicotinic Receptor Partial Agonist: (1) Binding and Functional Profile

Biton, B., Bergis, O. E., Galli, F., Alain, N., Lochead, A. W., Jegham, S., Godet, D., Lanneau, C., Santamaria, R., Chesney, F., et al. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301189 · Cited by 174

Expression of nicotinic acetylcholine receptor subunits in the cerebral cortex in Alzheimer’s disease: histotopographical correlation with amyloid plaques and hyperphosphorylated‐tau protein

Wevers, A., Monteggia, L. M., Nowacki, S., Bloch, W., Schütz, U., Lindstrom, J. M., Pereira, E. F. R., Eisenberg, H. M., Giacobini, E., de Vos, R. A. I., et al. (1999) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.1999.00676.x · Cited by 159

Low-frequency activation of the NMDA receptor system can prevent the induction of LTP

Coan, E. J., Irving, A. J., & Collingridge, G. L. (1989) · Neuroscience Letters · doi:10.1016/0304-3940(89)90038-4 · Cited by 157

Synaptic memory mechanisms: Alzheimer's disease amyloid β-peptide-induced dysfunction

Rowan, M. J., Klyubin, I. V., Wang, Q., Hu, N., & Anwyl, R. (2007) · Biochemical Society Transactions · doi:10.1042/bst0351219 · Cited by 154

Amyloid Fibril Toxicity in Alzheimer's Disease and Diabetesa

Lorenzo, A., & Yankner, B. A. (1996) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1996.tb34406.x · Cited by 151

Place cell firing correlates with memory deficits and amyloid plaque burden in Tg2576 Alzheimer mouse model

Cacucci, F., Yi, M., Wills, T. J., Chapman, P. F., & O'Keefe, J. M. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0802908105 · Cited by 148

Glutamate release from microglia via glutamate transporter is enhanced by amyloid-beta peptide

Noda, M., Nakanishi, H., & Akaike, N. (1999) · Neuroscience · doi:10.1016/s0306-4522(99)00036-6 · Cited by 144

Activation of nicotinic acetylcholine receptors induces long‐term potentiation in vivo in the intact mouse dentate gyrus

Matsuyama, S., Matsumoto, A., Enomoto, T., & Nishizaki, T. (2000) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2000.00259.x · Cited by 143

Effects of memantine and MK‐801 on NMDA‐induced currents in cultured neurones and on synaptic transmission and LTP in area CA1 of rat hippocampal slices

Frankiewicz, T., Potier, B., Bashir, Z. I., Collingridge, G. L., & Parsons, C. G. (1996) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1996.tb15245.x · Cited by 135

Small Molecule, Non-Peptide p75NTR Ligands Inhibit Aβ-Induced Neurodegeneration and Synaptic Impairment

Yang, T., Knowles, J. K., Lu, Q., Zhang, H., Arancio, O., Moore, L. A., Chang, T., Wang, Q., Andreasson, K. I., Rajadas, J., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003604 · Cited by 134

The role of nicotinic acetylcholine receptors in Alzheimer’s disease

Oddo, S., & LaFerla, F. M. (2006) · Journal of Physiology-Paris · doi:10.1016/j.jphysparis.2005.12.080 · Cited by 132

Nicotinic Acetylcholine Receptors at Glutamate Synapses Facilitate Long-Term Depression or Potentiation

Ge, S., & Dani, J. A. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.0542-05.2005 · Cited by 132

Chronic Psychosocial Stress Exacerbates Impairment of Cognition and Long-Term Potentiation in β-Amyloid Rat Model of Alzheimer's Disease

Srivareerat, M., Tran, T. T., Alzoubi, K. H., & Alkadhi, K. A. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.08.021 · Cited by 128

β-Amyloid selectively augments NMDA receptor-mediated synaptic transmission in rat hippocampus

Wu, J., Anwyl, R., & Rowan, M. J. (1995) · Neuroreport · doi:10.1097/00001756-199511270-00031 · Cited by 128

Chronic nicotine restores normal Aβ levels and prevents short-term memory and E-LTP impairment in Aβ rat model of Alzheimer's disease

Srivareerat, M., Tran, T. T., Salim, S., Aleisa, A. M., & Alkadhi, K. A. (2009) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2009.04.015 · Cited by 122

Soluble Arctic amyloid β protein inhibits hippocampal long‐term potentiation in vivo

Klyubin, I. V., Walsh, D. M., Cullen, W. K., Fadeeva, J. V., Anwyl, R., Selkoe, D. J., & Rowan, M. J. (2004) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2004.03389.x · Cited by 121

Involvement of β-site APP cleaving enzyme 1 (BACE1) in amyloid precursor protein-mediated enhancement of memory and activity-dependent synaptic plasticity

Ma, H., Lesné, S., Kotilinek, L., Steidl-Nichols, J. V., Sherman, M. A., Younkin, L. H., Younkin, S. G., Forster, C. L., Sergeant, N., Delacourte, A., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0609521104 · Cited by 121

No hippocampal neuron or synaptic bouton loss in learning-impaired aged β-Amyloid precursor protein-null mice

Phinney, A. L., Calhoun, M. E., Wolfer, D. P., Lipp, H., Zheng, H., & Jucker, M. (1999) · Neuroscience · doi:10.1016/s0306-4522(98)00645-9 · Cited by 120

Binding Sites of Amyloid β-Peptide in Cell Plasma Membrane and Implications for Alzheimers Disease

Verdier, Y., & Penke, B. (2004) · Current Protein and Peptide Science · doi:10.2174/1389203043486937 · Cited by 118

Nicotinic receptor‐mediated enhancement of long‐term potentiation involves activation of metabotropic glutamate receptors and ryanodine‐sensitive calcium stores in the dentate gyrus

Welsby, P. J., Rowan, M. J., & Anwyl, R. (2006) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2006.05187.x · Cited by 118

BACE1 Knock-Outs Display Deficits in Activity-Dependent Potentiation of Synaptic Transmission at Mossy Fiber to CA3 Synapses in the Hippocampus

Wang, H., Song, L., Laird, F. M., Wong, P. C., & Lee, H. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.2440-08.2008 · Cited by 116

Deregulation of NMDA-receptor function and down-stream signaling in APP[V717I] transgenic mice

Dewachter, I., Filipkowski, R. K., Priller, C., Ris, L., Neyton, J., Croes, S., Terwel, D., Gysemans, M., Devijver, H., Borghgraef, P., et al. (2007) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.06.011 · Cited by 116

Amyloid precursor protein knockout mice show age-dependent deficits in passive avoidance learning

Sénéchal, Y., Kelly, P. H., & Dev, K. K. (2007) · Behavioural Brain Research · doi:10.1016/j.bbr.2007.08.003 · Cited by 113

β-Amyloid peptide-derived, oxygen-dependent free radicals inhibit glutamate uptake in cultured astrocytes: implications for Alzheimerʼs disease

Harris‐White, M. E., Carney, J. M., Cole, P. S., Hensley, K., Howard, B. J., Martin, L., Bummer, P. M., Wang, Y., Pedigo, N. W., & Butterfield, D. A. (1995) · Neuroreport · doi:10.1097/00001756-199510020-00013 · Cited by 112

Uncompetitive NMDA receptor antagonists attenuate NMDA-induced impairment of passive avoidance learning and LTP

Zajaczkowski, W., Frankiewicz, T., Parsons, C. G., & Danysz, W. (1997) · Neuropharmacology · doi:10.1016/s0028-3908(97)00070-1 · Cited by 112

α7 Nicotinic acetylcholine receptor as a target to rescue deficit in hippocampal LTP induction in β-amyloid infused rats

Chen, L., Yamada, K., Nabeshima, T., & Sokabe, M. (2005) · Neuropharmacology · doi:10.1016/j.neuropharm.2005.09.018 · Cited by 111

Long-Term Potentiation Is Increased in the CA1 Area of the Hippocampus of APPswe/ind CRND8 Mice

Jolas, T. (2002) · Neurobiology of Disease · doi:10.1006/nbdi.2002.0557 · Cited by 100

Amyloid 1-42 peptide alters the gating of human and mouse -bungarotoxin-sensitive nicotinic receptors

Grassi, F., Palma, E., Tonini, R., Amici, M., Ballivet, M., & Eusebi, F. (2003) · The Journal of Physiology · doi:10.1113/jphysiol.2002.035436 · Cited by 98

Role of Amyloid- Glycine 33 in Oligomerization, Toxicity, and Neuronal Plasticity

Harmeier, A., Wozny, C., Rost, B. R., Munter, L. M., Hua, H., Georgiev, O., Beyermann, M., Hildebrand, P. W., Weise, C., Schaffner, W., et al. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.1336-09.2009 · Cited by 97

β‐Amyloid peptide fragment 25–35 potentiates the calcium‐dependent release of excitatory amino acids from depolarized hippocampal slices

Arias, C., Arrieta, I., & Tapia, R. (1995) · Journal of Neuroscience Research · doi:10.1002/jnr.490410416 · Cited by 96

NMDA receptor regulation by amyloid-β does not account for its inhibition of LTP in rat hippocampus

Raymond, C. R., Ireland, D. R., & Abraham, W. C. (2003) · Brain Research · doi:10.1016/s0006-8993(03)02269-8 · Cited by 94

Physiological Roles of Amyloid-?? and Implications for its Removal in Alzheimer???s Disease

Bishop, G. M., & Robinson, S. R. (2004) · Drugs & Aging · doi:10.2165/00002512-200421100-00001 · Cited by 94

Preclinical Characterization of A‐582941: A Novel α7 Neuronal Nicotinic Receptor Agonist with Broad Spectrum Cognition‐Enhancing Properties

Tietje, K. R., Anderson, D. J., Bitner, R., Blomme, E., Brackemeyer, P. J., Briggs, C., Browman, K. E., Bury, D., Curzon, P., Drescher, K., et al. (2008) · CNS Neuroscience & Therapeutics · doi:10.1111/j.1527-3458.2008.00037.x · Cited by 91

Ventral hippocampal α4β2 nicotinic receptors and chronic nicotine effects on memory

Bancroft, A., & Levin, E. D. (2000) · Neuropharmacology · doi:10.1016/s0028-3908(00)00099-x · Cited by 89

Expression of nicotinic acetylcholine receptors in Alzheimer’s disease: postmortem investigations and experimental approaches

Wevers, A., Burghaus, L., Moser, N., Witter, B., Steinlein, O. K., Schütz, U., Achnitz, B., Krempel, U., Nowacki, S., Pilz, K., et al. (2000) · Behavioural Brain Research · doi:10.1016/s0166-4328(00)00215-1 · Cited by 87

Soluble amyloid- peptides potently disrupt hippocampal synaptic plasticity in the absence of cerebrovascular dysfunction in vivo

Hu, N., Smith, I. M., Walsh, D. M., & Rowan, M. J. (2008) · Brain · doi:10.1093/brain/awn174 · Cited by 87

β-Amyloid25-35 inhibits glutamate uptake in cultured neurons and astrocytes: modulation of uptake as a survival mechanism

Fernández-Tomé, P., Brera, B., Arévalo, M., & CEBALLOS, M. L. D. (2004) · Neurobiology of Disease · doi:10.1016/j.nbd.2003.12.006 · Cited by 85

Effects of an exogenous β-amyloid peptide on retention for spatial learning

McDonald, M. P., Dahl, E. E., Overmier, J. B., Mantyh, P. W., & Cleary, J. P. (1994) · Behavioral and Neural Biology · doi:10.1016/s0163-1047(05)80059-7 · Cited by 83

Network dysfunction in Alzheimer's disease: does synaptic scaling drive disease progression?

Small, D. H. (2008) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2007.12.006 · Cited by 83

β-amyloid-(1–40) increases long-term potentiation in rat hippocampus in vitro

Wu, J., Anwyl, R., & Rowan, M. J. (1995) · European Journal of Pharmacology · doi:10.1016/0014-2999(95)00539-w · Cited by 80

Novel modulatory mechanisms revealed by the sustained application of nicotine in the guinea‐pig hippocampus in vitro

Mann, E. O., & Greenfield, S. A. (2003) · The Journal of Physiology · doi:10.1113/jphysiol.2003.045492 · Cited by 79

Nicotinic Acetylcholine Receptors

Wiley, J., York, N., Colquhoun, D., Unwin, P. N. T., Shelley, C., Hatton, C., & Sivilotti, L. G. (2004) · Encyclopedic Dictionary of Genetics, Genomics and Proteomics · doi:10.1002/0471684228.egp08474 · Cited by 79

Differential effects of unaggregated and aggregated amyloid β protein (1–40) on K+ channel currents in primary cultures of rat cerebellar granule and cortical neurones

Ramsden, M., Plant, L. D., Webster, N. J., Vaughan, P. F. T., Henderson, Z., & Pearson, H. A. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00618.x · Cited by 76

α2β1 and αVβ1 integrin signaling pathways mediate amyloid-β-induced neurotoxicity

Wright, S., Malinin, N. L., Powell, K. A., Yednock, T. A., Rydel, R. E., & Griswold‐Prenner, I. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.12.002 · Cited by 75

α7‐Nicotinic acetylcholine receptors mediate an Aβ1−42‐induced increase in the level of acetylcholinesterase in primary cortical neurones

Fodero, L. R., Mok, S. S., Lošić, D., Martin, L. L., Aguilar, M., Barrow, C. J., Livett, B. G., & Small, D. H. (2004) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.02296.x · Cited by 75

Amyloid β-protein induced electrophysiological changes are dependent on aggregation state: N-methyl-d-aspartate (NMDA) versus non-NMDA receptor/channel activation

Ye, C., Walsh, D. M., Selkoe, D. J., & Hartley, D. M. (2004) · Neuroscience Letters · doi:10.1016/j.neulet.2004.05.060 · Cited by 75

Bridging Physiology and Pathology in AD

Kim, D., & Tsai, L. (2009) · Cell · doi:10.1016/j.cell.2009.05.042 · Cited by 72

Aβ1–42 modulation of Akt phosphorylation via α7 nAChR and NMDA receptors

Abbott, J. J., Howlett, D. R., Francis, P. T., & Williams, R. J. (2007) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.01.003 · Cited by 71

Protection against Aβ-mediated rapid disruption of synaptic plasticity and memory by memantine

Klyubin, I., Wang, Q., Reed, M. N., Irving, E. A., Upton, N., Hofmeister, J., Cleary, J. P., Anwyl, R., & Rowan, M. J. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2009.04.005 · Cited by 69 · cited 5×

Effects of β-Amyloid-(25-35) Peptides on Radioligand Binding to Excitatory Amino Acid Receptors and Voltage-Dependent Calcium Channels: Evidence for a Selective Affinity for the Glutamate and Glycine Recognition Sites of the NMDA Receptor

Cowburn, R. F., Wiehager, B., Trief, E., Mo, L., & Sundström, E. (1997) · Neurochemical Research · doi:10.1023/a:1021942109490 · Cited by 69

Compartmentalized NMDA receptor signalling to survival and death

Soriano, F. X., & Hardingham, G. E. (2007) · The Journal of Physiology · doi:10.1113/jphysiol.2007.138875 · Cited by 68

Differential physiologic responses of α7 nicotinic acetylcholine receptors to β‐amyloid1–40 and β‐amyloid1–42

Lee, D. H. S., & Wang, H.-Y. (2003) · Journal of Neurobiology · doi:10.1002/neu.10203 · Cited by 67

Coupling of muscarinic receptors to GTP proteins in postmortem human brain--alterations in Alzheimer's disease.

Warpman, U., Alafuzoff, I., & Nordberg, A. (1993) · Neuroscience Letters · doi:10.1016/0304-3940(93)90103-r · Cited by 67

Unexpected antipsychotic-like activity with the muscarinic receptor ligand (5R,6R)6-(3-propylthio-1,2,5-thiadiazol-4-yl)-1-azabicyclo[3.2.1]octane

Bymaster, F. P., Shannon, H. E., Rasmussen, K., DeLapp, N. W., Mitch, C. H., Ward, J. S., Calligaro, D. O., Ludvigsen, T. S., Sheardown, M. J., Olesen, P. H., et al. (1998) · European Journal of Pharmacology · doi:10.1016/s0014-2999(98)00487-7 · Cited by 65

β-Amyloid produces a delayed NMDA receptor- dependent reduction in synaptic transmission in rat hippocampus

Cullen, W. K., Wu, J., Anwyl, R., & Rowan, M. J. (1996) · Neuroreport · doi:10.1097/00001756-199612200-00018 · Cited by 65

Amyloid β‐protein fragments 25–35 and 31–35 potentiate long‐term depression in hippocampal CA1 region of rats in vivo

Cheng, L., Yin, W., Zhang, J., & Qi, J. (2008) · Synapse · doi:10.1002/syn.20599 · Cited by 65

Intracellular mechanisms underlying the nicotinic enhancement of LTP in the rat dentate gyrus

Welsby, P. J., Rowan, M. J., & Anwyl, R. (2008) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2008.06562.x · Cited by 64

The Cholinergic Neuronal Phenotype in Alzheimer's Disease

Blusztajn, J. K., & Berse, B. (2000) · Metabolic Brain Disease · doi:10.1007/bf02680013 · Cited by 64

Does modulation of glutamatergic function represent a viable therapeutic strategy in Alzheimer's disease?

LAWLOR, B. A., & Davis, K. L. (1992) · Biological Psychiatry · doi:10.1016/0006-3223(92)90227-q · Cited by 63

Nicotinic receptors and Alzheimer's disease

Bourin, M., Ripoll, N., & Dailly, É. (2003) · Current Medical Research and Opinion · doi:10.1185/030079903125001631 · Cited by 62

High content screen microscopy analysis of Aβ1–42-induced neurite outgrowth reduction in rat primary cortical neurons: Neuroprotective effects of α7 neuronal nicotinic acetylcholine receptor ligands

Hu, M., Schurdak, M. E., Puttfarcken, P. S., Kouhen, R. E., Gopalakrishnan, M., & Li, J. (2007) · Brain Research · doi:10.1016/j.brainres.2007.03.051 · Cited by 60

Nicotinic receptor agonists and antagonists increase sAPPα secretion and decrease Aβ levels in vitro

Mousavi, M. T., & Hellström‐Lindahl, E. (2008) · Neurochemistry International · doi:10.1016/j.neuint.2008.12.001 · Cited by 60

Toxicity of β-amyloid in HEK293 cells expressing NR1/NR2A or NR1/NR2B N-methyl-d-aspartate receptor subunits

Domingues, A. M. D. J., Almeida, S., DACRUZESILVA, E., Oliveira, C. R., & Rego, A. C. (2007) · Neurochemistry International · doi:10.1016/j.neuint.2007.03.001 · Cited by 60

Enhancement of NMDA responses by β-amyloid peptides in the hippocampus in vivo

Molnár, Z., Soós, K., Lengyel, I., Penke, B., Szegedi, V., & Budai, D. (2004) · Neuroreport · doi:10.1097/01.wnr.0000134471.06244.d2 · Cited by 60

Contribution of neural networks to Alzheimer disease's progression

Savioz, A., Leuba, G., Vallet, P. G., & Walzer, C. (2009) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2009.06.006 · Cited by 59

Cognitive dysfunction induced by sequential injection of amyloid-β and ibotenate into the bilateral hippocampus; protection by memantine and MK-801

Nakamura, S., Murayama, N., Noshita, T., Katsuragi, R., & Ohno, T. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2006.07.049 · Cited by 58

Chapter 12 Modulation of LTP induction by NMDA receptor activation and nitric oxide release

Zorumski, C. F., & Izumi, Y. (1998) · Progress in brain research · doi:10.1016/s0079-6123(08)63207-0 · Cited by 57

Nicotinic acetylcholine receptor immunohistochemistry in Alzheimer's disease and dementia with Lewy bodies: differential neuronal and astroglial pathology

Teaktong, T., Graham, A. J., COURT, J. A., Perry, R. H., Jaros, E., Johnson, M., Hall, R., & Perry, E. K. (2004) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2004.06.015 · Cited by 57

Nicotinic Receptors Differentially Regulate N-Methyl-d-aspartate Damage in Acute Hippocampal Slices

Ferchmin, P. A., Pérez, D., Eterović, V. A., & de Vellis, J. (2003) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.048173 · Cited by 57

Amyloid β Protein Modulates Glutamate-Mediated Neurotransmission in the Rat Basal Forebrain: Involvement of Presynaptic Neuronal Nicotinic Acetylcholine and Metabotropic Glutamate Receptors

Chin, J. H., Ma, L., MacTavish, D., & Jhamandas, J. H. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.1843-07.2007 · Cited by 56

β-Amyloid-related peptides potentiate K+-evoked glutamate release from adult rat hippocampal slices

Kabogo, D., Rauw, G. A., Amritraj, A., Baker, G. B., & Kar, S. (2008) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2008.08.009 · Cited by 55

Synaptic Retrogenesis and Amyloid-β in Alzheimer's Disease

Wasling, P., Daborg, J., Riebe, I., Andersson, M., Portelius, E., Blennow, K., Hanse, E., & Zetterberg, H. (2009) · Journal of Alzheimer s Disease · doi:10.3233/jad-2009-0918 · Cited by 53

Bilateral injections of βA(25–35)+IBO into the hippocampus disrupts acquisition of spatial learning in the rat

Dornan, W. A., Kang, D. E., McCampbell, A., & Kang, E. E. (1993) · Neuroreport · doi:10.1097/00001756-199311180-00018 · Cited by 51

Effects of Nicotine

Burn, J. H. (1968) · BMJ · doi:10.1136/bmj.1.5587.310-b · Cited by 50

Impairment of muscarinic transmission in transgenic APPswe/PS1dE9 mice

Machová, E., Jakubík, J., Michal, P., Oksman, M., Iivonen, H., Tanila, H., & Doležal, V. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2006.10.029 · Cited by 50

Aromatic residues at position 55 of rat α7 nicotinic acetylcholine receptors are critical for maintaining rapid desensitization

Gay, E. A., Giniatullin, R. A., Skorinkin, A., & Yakel, J. L. (2007) · The Journal of Physiology · doi:10.1113/jphysiol.2007.149492 · Cited by 49

Memory performance is related to amyloid and tau pathology in the hippocampus

Reitz, C., Honig, L. S., Vonsattel, J. P., Tang, M.-X., & Mayeux, R. P. (2009) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2008.154146 · Cited by 49

Stereospecific interactions are necessary for Alzheimer disease amyloid-β toxicity.

Ciccotosto, G., Tew, D., Drew, S., Smith, D. G., Johanssen, T., Lal, V., Lau, T., Perez, K., Curtain, C., Wade, J., et al. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2009.02.018 · Cited by 48

Incubation of nerve endings with a physiological concentration of Aβ1-42 activates CaV2.2(N-Type)-voltage operated calcium channels and acutely increases glutamate and noradrenaline release

Bobich, J. A., Zheng, Q., & Campbell, A. (2004) · Journal of Alzheimer s Disease · doi:10.3233/jad-2004-6305 · Cited by 46

Mg2+and memantine block of rat recombinant NMDA receptors containing chimeric NR2A/2D subunits expressed inXenopus laevisoocytes

Wrighton, D. C., Baker, E. J., Chen, P. E., & Wyllie, D. J. A. (2007) · The Journal of Physiology · doi:10.1113/jphysiol.2007.143164 · Cited by 46

Nicotine Enhances the Depressive Actions of Aβ1–40 on Long-Term Potentiation in the Rat Hippocampal CA1 Region In Vivo

Freir, D. B., & Herron, C. E. (2003) · Journal of Neurophysiology · doi:10.1152/jn.00996.2002 · Cited by 45

The Role of β-Amyloid Protein in Synaptic Function: Implications for Alzheimers Disease Therapy

Peña‐Ortega, F., Gutiérrez-Lerma, A. I., Quiroz‐Baez, R., & Arias, C. (2006) · Current Neuropharmacology · doi:10.2174/157015906776359531 · Cited by 45

Unraveling in vivo Functions of Amyloid Precursor Protein: Insights from Knockout and Knockdown Studies

Sénéchal, Y., Larmet, Y., & Dev, K. K. (2006) · Neurodegenerative Diseases · doi:10.1159/000094772 · Cited by 43

αv integrins mediate beta-amyloid induced inhibition of long-term potentiation

Wang, Q., Klyubin, I., Wright, S., Griswold-Prenner, I., Rowan, M. J., & Anwyl, R. (2008) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.03.018 · Cited by 42

Impaired muscarinic regulation of excitatory synaptic transmission in the APPswe/PS1dE9 mouse model of Alzheimer's disease

Goto, Y., Niidome, T., Hongo, H., Akaike, A., Kihara, T., & Sugimoto, H. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2008.01.030 · Cited by 39

Divergent effects of Aβ1–42 on ionotropic glutamate receptor-mediated responses in CA1 neurons in vivo

Szegedi, V., Juhász, G., Budai, D., & Penke, B. (2005) · Brain Research · doi:10.1016/j.brainres.2005.09.014 · Cited by 39

Beta-amyloid blocks high frequency stimulation induced LTP but not nicotine enhanced LTP

Welsby, P. J., Rowan, M. J., & Anwyl, R. (2007) · Neuropharmacology · doi:10.1016/j.neuropharm.2007.05.013 · Cited by 39

The α7 nicotinic acetylcholine receptor-selective antagonist, methyllycaconitine, partially protects against β-amyloid1–42 toxicity in primary neuron-enriched cultures

Martin, S. E., de Fiebre, N. E. C., & de Fiebre, C. M. (2004) · Brain Research · doi:10.1016/j.brainres.2004.07.016 · Cited by 39

Nicotine compensates for the loss of cholinergic function to enhance long-term potentiation induction

Yamazaki, Y., Hamaue, N., & Sumikawa, K. (2002) · Brain Research · doi:10.1016/s0006-8993(02)02935-9 · Cited by 39

α4β2 nicotinic acetylcholine receptors are required for the amyloid β protein-induced suppression of long-term potentiation in rat hippocampal CA1 region in vivo

Wu, M., He, Y., Guo, F., & Qi, J. (2008) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2008.06.005 · Cited by 30

Metabolic Brain Disease

(2017) · Elsevier eBooks · doi:10.1016/b978-0-323-47778-9.50239-7 · Cited by 22

Glutamatergic synaptic depression by synthetic amyloid β‐peptide in the medial septum

Santos‐Torres, J., de la Fuente, A., Criado, J. M., Riolobos, A. S., Heredia, M., & Yajeya, J. (2006) · Journal of Neuroscience Research · doi:10.1002/jnr.21150 · Cited by 21

A brief, but repeated, swimming protocol is sufficient to overcome amyloid β‐protein inhibition of hippocampal long‐term potentiation

Li, S., Feig, L. A., & Hartley, D. M. (2007) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2007.05760.x · Cited by 9

Pathogenesis of Alzheimer disease

Pavlović, D. M., Pavlovic, A. M., & Zugic, S. (2007) · Vojnosanitetski pregled · doi:10.2298/vsp0711765p · Cited by 8

Untitled work

(1999) · doi:10.1002/1531-8249(199912)46:6

Hippocampus in health and disease: An overview

Dhikav, V., & Anand, K. S. (2012) · Annals of Indian Academy of Neurology · doi:10.4103/0972-2327.104323 · Cited by 603

S-Glutathionylation: From Molecular Mechanisms to Health Outcomes

Xiong, Y., Uys, J. D., Tew, K. D., & Townsend, D. M. (2011) · Antioxidants & Redox Signaling · doi:10.1089/ars.2010.3540 · Cited by 314

NMDA receptors in nervous system diseases

Zhou, Q., & Sheng, M. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.03.030 · Cited by 304

The cellular prion protein mediates neurotoxic signalling of β‐sheet‐rich conformers independent of prion replication

Resenberger, U. K., Harmeier, A., Woerner, A. C., Goodman, J. L., Müller, V., Krishnan, R., Vabulas, R. M., Kretzschmar, H. A., Lindquist, S. L., Hartl, F. U., et al. (2011) · The EMBO Journal · doi:10.1038/emboj.2011.86 · Cited by 250

The roles of TNF in brain dysfunction and disease

Clark, I. A., Alleva, L. M., & Vissel, B. (2010) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2010.08.007 · Cited by 239

Amyloid β: linking synaptic plasticity failure to memory disruption in Alzheimer’s disease

Ma, T., & Klann, E. (2011) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07506.x · Cited by 140

A mechanistic hypothesis for the impairment of synaptic plasticity by soluble Aβ oligomers from Alzheimer’s brain

Li, S., & Selkoe, D. J. (2020) · Journal of Neurochemistry · doi:10.1111/jnc.15007 · Cited by 263

O2‐02–02: Soluble amyloid β‐protein dimers isolated directly from Alzheimer's disease patients potently impair synaptic plasticity and memory

Shankar, G. M., Li, S., Mehta, T., García-Muñoz, A., Shepardson, N. E., Smith, I. M., Brett, F. M., Farrell, M. A., Rowan, M. J., Lemere, C. A., et al. (2008) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2008.05.314 · Cited by 2

Glutamatergic synaptic plasticity and dysfunction in Alzheimer disease: Emerging mechanisms

Benarroch, E. E. (2018) · Neurology · doi:10.1212/wnl.0000000000005807 · Cited by 115

Maladie d’Alzheimer, peptide β-amyloïde et synapses

Hémar, A., & Mulle, C. (2011) · médecine/sciences · doi:10.1051/medsci/2011278015 · Cited by 14